Medicare Enrolled
Dr. Patrick McGinty, MD
Cardiovascular Disease · Encinitas, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McGinty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McGinty?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McGinty
Dr. Patrick McGinty is a cardiovascular disease specialist in Encinitas, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. McGinty performed 3,305 Medicare services across 2,123 unique beneficiaries.
Between the years covered by Open Payments, Dr. McGinty received a total of $13,122 from 56 pharmaceutical and/or device companies across 540 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McGinty is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 33% volume in CA
$13,122 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,305
Medicare services
Top 33% in CA for cardiovascular disease
2,123
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~184 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
718 | $100 | $230 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
385 | $7 | $36 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
352 | $76 | $600 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
336 | $42 | $204 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
257 | $12 | $36 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
247 | $98 | $216 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
178 | $387 | $1,058 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
178 | $54 | $154 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
176 | $163 | $455 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
118 | $143 | $419 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
71 | $94 | $230 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $75 | $160 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
43 | $11 | $26 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
43 | $21 | $43 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $144 | $308 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
30 | $11 | $33 |
| New patient office visit, complex (60-74 min) | 30 | $166 | $435 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
13 | $71 | $160 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
12 | $20 | $59 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
12 | $3 | $8 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
11 | $6 | $31 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.7% high complexity
33.2% medium
61.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,122
Total received (2018-2024)
Avg $1,875/year across 7 years
Top 23% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
540
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,152 (92.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$971 (7.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,833
2023
$2,524
2022
$2,471
2021
$800
2020
$404
2019
$2,219
2018
$2,871
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$218
Amgen Inc.
$170
AstraZeneca Pharmaceuticals LP
$141
Kestra Medical Technology Services, Inc.
$138
iRhythm Technologies, Inc.
$136
Esperion Therapeutics, Inc.
$116
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$103
Medtronic, Inc.
$99
Actelion Pharmaceuticals US, Inc.
$97
Merck Sharp & Dohme LLC
$94
Janssen Pharmaceuticals, Inc
$78
PFIZER INC.
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$65
SANOFI-AVENTIS U.S. LLC
$54
Kiniksa Pharmaceuticals International, plc
$47
Chiesi USA, Inc.
$40
CVRx, Inc.
$36
Philips North America LLC
$24
Novo Nordisk Inc
$23
Baxter Healthcare
$22
Boston Scientific Corporation
$22
Abbott Laboratories
$17
Lexicon Pharmaceuticals, Inc.
$17
Top 3 companies account for 28.9% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$1,551
Novartis Pharmaceuticals Corporation
$1,135
PFIZER INC.
$1,075
Amgen Inc.
$772
Janssen Pharmaceuticals, Inc
$713
AstraZeneca Pharmaceuticals LP
$685
E.R. Squibb & Sons, L.L.C.
$664
Merck Sharp & Dohme LLC
$520
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$506
Abbott Laboratories
$487
Boehringer Ingelheim Pharmaceuticals, Inc.
$479
Esperion Therapeutics, Inc.
$458
Actelion Pharmaceuticals US, Inc.
$414
Boston Scientific Corporation
$374
iRhythm Technologies, Inc.
$296
CVRx, Inc.
$262
Medtronic Vascular, Inc.
$222
Gilead Sciences, Inc.
$202
Medtronic, Inc.
$201
Regeneron Healthcare Solutions, Inc.
$200
ABIOMED
$177
Otsuka America Pharmaceutical, Inc.
$146
Kestra Medical Technology Services, Inc.
$138
Amarin Pharma Inc.
$136
Biosense Webster, Inc.
$135
Kiniksa Pharmaceuticals, Ltd.
$132
Bardy Diagnostics, Inc.
$115
Allergan Inc.
$101
Chiesi USA, Inc.
$73
Merck Sharp & Dohme Corporation
$72
Novo Nordisk Inc
$65
Impulse Dynamics (USA) Inc.
$63
Kiniksa Pharmaceuticals International, plc
$47
BOSTON SCIENTIFIC CORPORATION
$46
Lundbeck LLC
$42
Lexicon Pharmaceuticals, Inc.
$41
HeartFlow, Inc.
$36
BIOTRONIK INC.
$24
Philips North America LLC
$24
Baxter Healthcare
$22
AtriCure, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$21
Philips Electronics North America Corporation
$19
Daiichi Sankyo Inc.
$18
Celgene Corporation
$18
W. L. Gore & Associates, Inc.
$18
AngioDynamics, Inc.
$18
Alnylam Pharmaceuticals Inc.
$17
Arrow Interventional, Inc.
$17
G Medical Diagnostic Services, Inc.
$16
Kowa Pharmaceuticals America, Inc.
$16
Amryt Pharma Holdings Ltd
$15
PORTOLA PHARMACEUTICALS, INC.
$14
Itamar Medical Inc
$14
Lantheus Medical Imaging, Inc.
$14
Tactile Systems Technology Inc
$13
Top 3 companies account for 28.7% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (CK4) MCOT · ANDEXXA · Allure CRT Pacemaker · Arcalyst · Assure WCD · Assurity Pacemaker · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOFORM Septal Occluder · CARTO 3 · CHANTIX · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Catheter - GuideLiner · Confirm Rx · Corlanor · DEFINITY · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Ellipse ICD · FARXIGA · FLEXITOUCH · Fortify Assura · General - Vascular Access · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · Impella · Inpefa · JARDIANCE · Juxtapid · KENGREAL · Kerendia · LEQVIO · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Orsiro Mission · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Quadra Assura CRT Defibrillator · RYBELSUS · Repatha · Reveal LINQ · SAMSCA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · VenaCure 1470 Pro · VenaSeal · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · XARELTO · ZIO Patch · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
224
Per 100K population
6.8
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL - ENCINITAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McGinty is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McGinty experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. McGinty performed 718 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McGinty receive payments from pharmaceutical companies?
Yes. Dr. McGinty received a total of $13,122 from 56 companies across 540 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McGinty's costs compare to other cardiologists in Encinitas?
Dr. McGinty's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McGinty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Encinitas
Browse cardiologists in Encinitas ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology